Black Diamond Therapeutics, Inc. (BDTX)

Last Closing Price: 2.97 (2026-04-24)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Black Diamond Therapeutics, Inc. (BDTX) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-15.12M
Cost of Goods Sold
--
--
$17.61M
$-17.61M
$2.49M
$-15.12M
$-15.12M
$-15.12M
$-15.12M
$-15.12M
$-15.12M
$-17.61M
$-17.54M
56.87M
57.56M
$-0.27
$-0.25
Balance Sheet Financials
$132.44M
$0.36M
$10.57M
$143.01M
$15.73M
--
$15.07M
$30.80M
$112.21M
$112.21M
$112.21M
57.14M
Cash Flow Statement Financials
$29.61M
$-44.91M
$-0.15M
$37.26M
$21.82M
$-15.44M
$6.63M
--
--
Fundamental Metrics & Ratios
8.42
--
--
--
--
--
--
--
--
--
--
$29.64M
--
--
--
--
--
--
--
-13.47%
-13.47%
-10.57%
-13.47%
$1.96
$0.51
$0.51